AbCellera Biologics Inc. AbCellera Biologics Inc.

AbCellera Biologics Inc.

ABCL

Rankning i aktier #4183
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the... AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and Company. Founded in 2012, the firm is headquartered in Vancouver, Canada.
Aktiekurs
$11.83
Senast synkroniserad: 2026-10-20
Marknadsvärde
$3.83B
Förändring (1 dag)
-0.88%
Förändring (1 år)
111.92%
Land
CA
Handel AbCellera Biologics Inc. (ABCL)

Kategori

Healthcare
Historik för aktiesplit för AbCellera Biologics Inc. (ABCL)
Aktien AbCellera Biologics Inc. (symbol: ABCL) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En ABCL-aktie köpt före Oct 21, 2026 motsvarar nu 0 ABCL-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL